WMT

87.28

-2.88%↓

COST

968.19

+0.2%↑

TGT

94.31

-10.89%↓

KR

70.66

+5.01%↑

GIS

61.01

+3.04%↑

WMT

87.28

-2.88%↓

COST

968.19

+0.2%↑

TGT

94.31

-10.89%↓

KR

70.66

+5.01%↑

GIS

61.01

+3.04%↑

WMT

87.28

-2.88%↓

COST

968.19

+0.2%↑

TGT

94.31

-10.89%↓

KR

70.66

+5.01%↑

GIS

61.01

+3.04%↑

WMT

87.28

-2.88%↓

COST

968.19

+0.2%↑

TGT

94.31

-10.89%↓

KR

70.66

+5.01%↑

GIS

61.01

+3.04%↑

WMT

87.28

-2.88%↓

COST

968.19

+0.2%↑

TGT

94.31

-10.89%↓

KR

70.66

+5.01%↑

GIS

61.01

+3.04%↑

Search

Lifecore Biomedical Inc

Gesloten

SectorConsumenten defensie

6.8 -5.42

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

6.71

Max

7

Belangrijke statistieken

By Trading Economics

Inkomsten

-1K

-6.6M

Verkoop

-5.3M

33M

K/W

Sectorgemiddelde

201.137

44.466

EPS

-0.253

Winstmarge

-20.179

Werknemers

524

EBITDA

-5.5M

Marktinformatie

By TradingEconomics

Marktkapitalisatie

59M

247M

Vorige openingsprijs

12.22

Vorige sluitingsprijs

6.8

Lifecore Biomedical Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

3 apr 2025, 23:04 UTC

Top Nieuws

JPMorgan Raises Risk of U.S., Global Recession to 60%

3 apr 2025, 22:40 UTC

Belangrijke Marktbewegers

Aldeyra Shares Fall on FDA Complete Response Letter for Dry Eye Disease Drug

3 apr 2025, 22:18 UTC

Acquisities, Fusies, Overnames

Quantum Corp. Gets Strategic Investment, Names New Financial Chief

3 apr 2025, 18:51 UTC

Acquisities, Fusies, Overnames

Capital One, Discover Merger Clears Regulatory Hurdle, Sources Tell The New York Times

3 apr 2025, 23:43 UTC

Marktinformatie

Gold Steady, Supported by Potential Safe-Haven Demand -- Market Talk

3 apr 2025, 23:41 UTC

Marktinformatie

Nikkei May Fall as U.S. Tariffs Raise Concerns About Global Growth -- Market Talk

3 apr 2025, 22:22 UTC

Acquisities, Fusies, Overnames

Is TikTok Getting Banned? What to Expect as the Deadline Approaches. -- Barrons.com

3 apr 2025, 22:21 UTC

Acquisities, Fusies, Overnames

Is TikTok Getting Banned? What to Expect as the Deadline Approaches. -- Barrons.com

3 apr 2025, 21:43 UTC

Top Nieuws
Winsten

The Day Trump's Tariffs Shook Wall Street and Corporate America -- 5th Update

3 apr 2025, 20:50 UTC

Marktinformatie

Financial Services Roundup: Market Talk

3 apr 2025, 20:50 UTC

Marktinformatie

Tech, Media & Telecom Roundup: Market Talk

3 apr 2025, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

3 apr 2025, 20:43 UTC

Marktinformatie

Plummeting Toronto Home Sales Reflect Trade, Political Uncertainty -- Market Talk

3 apr 2025, 20:34 UTC

Top Nieuws

Trump's Tariffs Were Supposed to Boost the Dollar, But Here's Why the Opposite Happened -- Heard on the Street -- 2nd Update

3 apr 2025, 20:23 UTC

Top Nieuws

Trump Tariffs Send Dow Industrials to 1600-Point Decline; Dollar Slumps -- WSJ

3 apr 2025, 20:15 UTC

Acquisities, Fusies, Overnames

Blackstone Life Sciences And Anthos Therapeutics Announce Novartis Has Completed The Acquisition Of Anthos Therapeutics In A Deal Valued At Up To $3.1B, With $925M Paid Upfront >BX

3 apr 2025, 19:55 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

3 apr 2025, 19:55 UTC

Marktinformatie

Dollar Weakens as Investors Seek Safety Elsewhere -- Market Talk

3 apr 2025, 19:21 UTC

Marktinformatie

Oil Futures Slide on U.S. Tariffs, OPEC+ Output Plan -- Market Talk

3 apr 2025, 19:15 UTC

Marktinformatie

U.S. Natural Gas Stays Focused on Weather, Storage -- Market Talk

3 apr 2025, 18:45 UTC

Marktinformatie

Market Talk Roundup: Latest on U.S. Politics

3 apr 2025, 18:45 UTC

Marktinformatie

Gold Drops In Tariff Fallout -- Market Talk

3 apr 2025, 18:39 UTC

Marktinformatie

U.S. Tariffs Could Give Natural Gas Edge Over Solar -- Market Talk

3 apr 2025, 18:38 UTC

Top Nieuws

Trump Tariffs Send Dow Industrials to 1400-Point Decline; Dollar Slumps -- WSJ

3 apr 2025, 18:30 UTC

Top Nieuws

Auto Industry Braces for Major Pain From Trump's Tariffs -- Analysis

3 apr 2025, 18:20 UTC

Marktinformatie

Uncertainty Still Roils Companies in Tariff Saga -- Market Talk

3 apr 2025, 18:18 UTC

Marktinformatie

Market Talk Roundup: Latest on U.S. Politics

3 apr 2025, 18:17 UTC

Marktinformatie

U.S. Workers Can't Match International Labor as Companies Consider Moving Supply Chains -- Market Talk

3 apr 2025, 18:04 UTC

Marktinformatie

US Sees More Job Openings in Construction, Transportation -- Market Talk

3 apr 2025, 17:55 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

Peer Vergelijking

Prijswijziging

Lifecore Biomedical Inc Prognose

Beoordelingsconsensus

By TipRanks

Buy

3 ratings

1

Buy

2

Hold

0

Sell

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Lifecore Biomedical Inc

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.